首页    期刊浏览 2024年09月18日 星期三
登录注册

文章基本信息

  • 标题:Is Anti-Cyclic Citrullinated Peptide Antibody a Good Value Biomarker for Alzheimer Disease?
  • 本地全文:下载
  • 作者:Rokhsareh Meamar ; Gholamreza Askari ; Majid Ghasemi
  • 期刊名称:INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE
  • 印刷版ISSN:2008-7802
  • 出版年度:2013
  • 卷号:4
  • 期号:Suppl 2
  • 页码:S201-S204
  • 语种:English
  • 出版社:ISFAHAN UNIVERSITY OF MEDICAL SCIENCES
  • 摘要:Background: Alzheimer's disease (AD) is one of the most important neurodegenerative disorder. Anti-cyclic citrullinated peptide (anti-CCP) may all be involved in the development of vascular disease such as AD. The aim of this study is detection of seropositivity for anti-CCP antibody in AD patients. Methods: In our study, 30 patients with AD and 29 healthy controls (age and-sex matched) were recruited. Homocysteine and anti-CCP was measured by spectrophotometrically and immunoassay. Results: Mean ± SE anti-CCP was higher significantly between AD (13.6 ± 3) and healthy subjects (4.8 ± 0.2) ( P = 0.006). In the patients, anti-CCP serum level was in high range (32.1%) of abnormal levels, but there was no significant difference in serum homocysteine in AD patients compared with controls. There is no correlation between anti-CCP and homocysteine levels in AD patients ( P = 0.75), but between age and anti-CCP level observed a significantly correlation ( P = 0.04). Conclusions: It needs more studies to clarify confirmation the role of anti-CCP antibody production in AD patients.
  • 关键词:Alzheimer's disease; anti-cyclic citrullinated peptide; homocysteine
国家哲学社会科学文献中心版权所有